Quantum Biopharma Ltd.
About Quantum Biopharma Ltd.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $27.3M
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $27.3M
- Shares outstanding
- 6.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 7, 2018
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 88% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Quantum Biopharma Ltd..
Write a review
News about Quantum Biopharma Ltd.
News & sentiment via Polygon.io
